Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial-Reference-Cited by-同舟云学术

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial

Published:2013-04-15 Issue:1 Volume:13 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Disertori Marcello,Franzosi Maria Grazia,Barlera Simona,Cosmi Franco,Quintarelli Silvia,Favero Chiara,Cappellini Glauco,Fabbri Gianna,Maggioni Aldo Pietro,Staszewsky Lidia,Moroni Luigi Andrea,Latini Roberto

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1186/1471-2261-13-28/fulltext.html

Reference26 articles.

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines: developed in collaboration with the European Heart Rhythm association and the Heart Rhythm Society. Circulation. 2006, 114: e257-e354.

2. Hart RG, Pearce LA, Aguilar MI: Metanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146: 857-867. 10.7326/0003-4819-146-12-200706190-00007.

3. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS: The net clinical benefit of warfarin in anticoagulation in atrial fibrillation. Ann Intern Med. 2009, 151: 297-305. 10.7326/0003-4819-151-5-200909010-00003.

4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. JAMA. 2001, 285: 2864-2870. 10.1001/jama.285.22.2864.

5. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki , Singer DE: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008, 51: 810-815. 10.1016/j.jacc.2007.09.065.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF Registry;The American Journal of Cardiology;2024-09

2. Editorial on the article «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation»;Kardiologiia;2024-08-31

3. Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond;Medicina;2024-03-26

4. Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes;Journal of the American College of Cardiology;2023-09

5. Trombofilia;Gaceta de M�xico;2022-01-18